Lupin rises on getting USFDA’s tentative approval for Arformoterol Tartrate Inhalation Solution

29 Apr 2020 Evaluate

Lupin is currently trading at Rs. 854.95, up by 0.60 points or 0.07% from its previous closing of Rs. 854.35 on the BSE.

The scrip opened at Rs. 868.95 and has touched a high and low of Rs. 872.75 and Rs. 850.00 respectively. So far 96482 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 906.35 on 27-Apr-2020 and a 52 week low of Rs. 505.00 on 13-Mar-2020.

Last one week high and low of the scrip stood at Rs. 906.35 and Rs. 814.00 respectively. The current market cap of the company is Rs. 38732.72 crore.

The promoters holding in the company stood at 46.93%, while Institutions and Non-Institutions held 38.99% and 13.80% respectively.

Lupin has received tentative approval for Arformoterol Tartrate Inhalation Solution 15 mcg (base)/2 mL, Unit-dose Vials, from the United States Food and Drug Administration (USFDA) to market a generic version of Brovana Inhalation Solution, 15 mcg/2 mL of Sunovion Pharmaceuticals Inc. (Sunovion).

Arformoterol Tartrate Inhalation Solution 15 mcg (base)/2 mL, Unit-dose Vials are indicated for the long-term maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2103.50 -9.80 (-0.46%)
24-Dec-2025 10:24 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1740.00
Dr. Reddys Lab 1258.15
Cipla 1498.05
Zydus Lifesciences 919.50
Lupin 2103.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×